Nutritional Supplementation Inhibits the Increase in Serum Malondialdehyde in Patients with Wet Age-Related Macular Degeneration

Abstract EN

Purpose.

To compare serum levels of malondialdehyde (MDA) in patients with wet age-related macular degeneration (wAMD), patients with dry AMD (dAMD), and patients without AMD and to evaluate the efficacy of nutritional supplementation for treating elevated serum MDA in patients with wAMD.

Methods.

MDA levels were measured in sera from 20 patients with wAMD, 20 with dAMD, and 24 without AMD.

Patients with wAMD were randomized to receive or not receive nutritional supplementation (10 patients in each group), and MDA levels were measured after 3 months of treatment.

Results.

MDA levels in patients with wAMD were significantly greater compared with patients without AMD.

In eyes with wAMD, there was a significant correlation between MDA levels and choroidal neovascularization lesion area.

Serum MDA levels decreased in most patients that received supplementation and significantly increased in those who did not.

Conclusion.

Baseline serum MDA levels were elevated in patients with wAMD, and MDA levels were directly correlated with choroidal neovascularization lesion area.

In addition, nutritional supplementation appeared to exert a protective effect against oxidative stress in patients with wAMD.